Pharma & Healthcare
Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 168265
- Pages: 101
- Figures: 107
- Views: 42
The global Drugs for Herpes Labialis (Oral Herpes) market size was US$ 2703 million in 2024 and is forecast to a readjusted size of US$ 3760 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.
The global Drugs for Herpes Labialis (Oral Herpes) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
By Type: (Dominant Segment vs High-Margin Innovation)
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
External Use
Oral
Injection
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GSK in Europe)
- Emerging Product Trends: Aciclovir adoption vs. Valacyclovir premiumization
- Demand-Side Dynamics: External Use growth in China vs. Oral potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Herpes Labialis (Oral Herpes) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Valacyclovir in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oral in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drugs for Herpes Labialis (Oral Herpes) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Global Drugs for Herpes Labialis (Oral Herpes) key players include GSK, Novartis, Teva, Mylan, Cadila, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 35%, followed by Europe, with a share about 30 percent. In terms of product, Rx Drugs is the largest segment, with a share about 90%. And in terms of application, the largest application is Oral, followed by External Use, and Injection, etc.
The global Drugs for Herpes Labialis (Oral Herpes) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
By Type: (Dominant Segment vs High-Margin Innovation)
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
External Use
Oral
Injection
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GSK in Europe)
- Emerging Product Trends: Aciclovir adoption vs. Valacyclovir premiumization
- Demand-Side Dynamics: External Use growth in China vs. Oral potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Herpes Labialis (Oral Herpes) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Valacyclovir in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oral in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drugs for Herpes Labialis (Oral Herpes) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Aciclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region (2020-2025)
2.4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.3 China Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.4 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2020-2025)
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drugs for Herpes Labialis (Oral Herpes) Representative Players
4 Breakdown Data by Application
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2020-2025)
4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Herpes Labialis (Oral Herpes) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2020-2025)
5.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue
5.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Analysis
5.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2024
5.5 Global Key Players of Drugs for Herpes Labialis (Oral Herpes) Head office and Area Served
5.6 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application
5.7 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.1.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.1.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.2.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.2.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.3.2.2 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.3.3.2 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.4.2.2 Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.4.3.2 Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 GSK
7.1.1 GSK Company Details
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction
7.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.1.5 GSK Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction
7.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Teva
7.3.1 Teva Company Details
7.3.2 Teva Business Overview
7.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction
7.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.3.5 Teva Recent Development
7.4 Mylan
7.4.1 Mylan Company Details
7.4.2 Mylan Business Overview
7.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction
7.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.4.5 Mylan Recent Development
7.5 Cadila
7.5.1 Cadila Company Details
7.5.2 Cadila Business Overview
7.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction
7.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.5.5 Cadila Recent Development
7.6 Apotex
7.6.1 Apotex Company Details
7.6.2 Apotex Business Overview
7.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.6.5 Apotex Recent Development
7.7 Daewoong Pharmaceutical
7.7.1 Daewoong Pharmaceutical Company Details
7.7.2 Daewoong Pharmaceutical Business Overview
7.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction
7.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.7.5 Daewoong Pharmaceutical Recent Development
7.8 Livzon
7.8.1 Livzon Company Details
7.8.2 Livzon Business Overview
7.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction
7.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.8.5 Livzon Recent Development
7.9 Luoxin
7.9.1 Luoxin Company Details
7.9.2 Luoxin Business Overview
7.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction
7.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.9.5 Luoxin Recent Development
7.10 Med shine
7.10.1 Med shine Company Details
7.10.2 Med shine Business Overview
7.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction
7.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.10.5 Med shine Recent Development
7.11 Bayer (Campho Phenique)
7.11.1 Bayer (Campho Phenique) Company Details
7.11.2 Bayer (Campho Phenique) Business Overview
7.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction
7.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.11.5 Bayer (Campho Phenique) Recent Development
7.12 Blistex
7.12.1 Blistex Company Details
7.12.2 Blistex Business Overview
7.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.12.5 Blistex Recent Development
7.13 Kelun
7.13.1 Kelun Company Details
7.13.2 Kelun Business Overview
7.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction
7.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.13.5 Kelun Recent Development
7.14 Hikma
7.14.1 Hikma Company Details
7.14.2 Hikma Business Overview
7.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction
7.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.14.5 Hikma Recent Development
7.15 Haiwang
7.15.1 Haiwang Company Details
7.15.2 Haiwang Business Overview
7.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction
7.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.15.5 Haiwang Recent Development
7.16 Carmex
7.16.1 Carmex Company Details
7.16.2 Carmex Business Overview
7.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.16.5 Carmex Recent Development
7.17 Cipher
7.17.1 Cipher Company Details
7.17.2 Cipher Business Overview
7.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction
7.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.17.5 Cipher Recent Development
8 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics
8.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
8.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers
8.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges
8.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Aciclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region (2020-2025)
2.4 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.3 China Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
2.5.4 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Type (2020-2025)
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Drugs for Herpes Labialis (Oral Herpes) Representative Players
4 Breakdown Data by Application
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size by Application (2020-2025)
4.2 Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Herpes Labialis (Oral Herpes) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2020-2025)
5.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drugs for Herpes Labialis (Oral Herpes) Revenue
5.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Analysis
5.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2024
5.5 Global Key Players of Drugs for Herpes Labialis (Oral Herpes) Head office and Area Served
5.6 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application
5.7 Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.1.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.1.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.2.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.2.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.3.2.2 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.3.3.2 China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025)
6.4.2.2 Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025)
6.4.3.2 Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 GSK
7.1.1 GSK Company Details
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Introduction
7.1.4 GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.1.5 GSK Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Introduction
7.2.4 Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Teva
7.3.1 Teva Company Details
7.3.2 Teva Business Overview
7.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Introduction
7.3.4 Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.3.5 Teva Recent Development
7.4 Mylan
7.4.1 Mylan Company Details
7.4.2 Mylan Business Overview
7.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Introduction
7.4.4 Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.4.5 Mylan Recent Development
7.5 Cadila
7.5.1 Cadila Company Details
7.5.2 Cadila Business Overview
7.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Introduction
7.5.4 Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.5.5 Cadila Recent Development
7.6 Apotex
7.6.1 Apotex Company Details
7.6.2 Apotex Business Overview
7.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.6.4 Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.6.5 Apotex Recent Development
7.7 Daewoong Pharmaceutical
7.7.1 Daewoong Pharmaceutical Company Details
7.7.2 Daewoong Pharmaceutical Business Overview
7.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Introduction
7.7.4 Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.7.5 Daewoong Pharmaceutical Recent Development
7.8 Livzon
7.8.1 Livzon Company Details
7.8.2 Livzon Business Overview
7.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Introduction
7.8.4 Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.8.5 Livzon Recent Development
7.9 Luoxin
7.9.1 Luoxin Company Details
7.9.2 Luoxin Business Overview
7.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Introduction
7.9.4 Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.9.5 Luoxin Recent Development
7.10 Med shine
7.10.1 Med shine Company Details
7.10.2 Med shine Business Overview
7.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Introduction
7.10.4 Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.10.5 Med shine Recent Development
7.11 Bayer (Campho Phenique)
7.11.1 Bayer (Campho Phenique) Company Details
7.11.2 Bayer (Campho Phenique) Business Overview
7.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Introduction
7.11.4 Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.11.5 Bayer (Campho Phenique) Recent Development
7.12 Blistex
7.12.1 Blistex Company Details
7.12.2 Blistex Business Overview
7.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.12.4 Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.12.5 Blistex Recent Development
7.13 Kelun
7.13.1 Kelun Company Details
7.13.2 Kelun Business Overview
7.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Introduction
7.13.4 Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.13.5 Kelun Recent Development
7.14 Hikma
7.14.1 Hikma Company Details
7.14.2 Hikma Business Overview
7.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Introduction
7.14.4 Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.14.5 Hikma Recent Development
7.15 Haiwang
7.15.1 Haiwang Company Details
7.15.2 Haiwang Business Overview
7.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Introduction
7.15.4 Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.15.5 Haiwang Recent Development
7.16 Carmex
7.16.1 Carmex Company Details
7.16.2 Carmex Business Overview
7.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Introduction
7.16.4 Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.16.5 Carmex Recent Development
7.17 Cipher
7.17.1 Cipher Company Details
7.17.2 Cipher Business Overview
7.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Introduction
7.17.4 Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
7.17.5 Cipher Recent Development
8 Drugs for Herpes Labialis (Oral Herpes) Market Dynamics
8.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
8.2 Drugs for Herpes Labialis (Oral Herpes) Market Drivers
8.3 Drugs for Herpes Labialis (Oral Herpes) Market Challenges
8.4 Drugs for Herpes Labialis (Oral Herpes) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Region (2020-2025)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2020-2025)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2020-2025)
Table 15. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drugs for Herpes Labialis (Oral Herpes) Application
Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players (2020-2025)
Table 20. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2024)
Table 21. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Headquarters and Area Served
Table 24. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application
Table 25. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 29. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 33. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 37. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 41. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 43. GSK Company Details
Table 44. GSK Business Overview
Table 45. GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table 46. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 47. GSK Recent Development
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table 51. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Teva Company Details
Table 54. Teva Business Overview
Table 55. Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table 56. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 57. Teva Recent Development
Table 58. Mylan Company Details
Table 59. Mylan Business Overview
Table 60. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table 61. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 62. Mylan Recent Development
Table 63. Cadila Company Details
Table 64. Cadila Business Overview
Table 65. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table 66. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 67. Cadila Recent Development
Table 68. Apotex Company Details
Table 69. Apotex Business Overview
Table 70. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table 71. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 72. Apotex Recent Development
Table 73. Daewoong Pharmaceutical Company Details
Table 74. Daewoong Pharmaceutical Business Overview
Table 75. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table 76. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 77. Daewoong Pharmaceutical Recent Development
Table 78. Livzon Company Details
Table 79. Livzon Business Overview
Table 80. Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table 81. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 82. Livzon Recent Development
Table 83. Luoxin Company Details
Table 84. Luoxin Business Overview
Table 85. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table 86. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 87. Luoxin Recent Development
Table 88. Med shine Company Details
Table 89. Med shine Business Overview
Table 90. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table 91. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 92. Med shine Recent Development
Table 93. Bayer (Campho Phenique) Company Details
Table 94. Bayer (Campho Phenique) Business Overview
Table 95. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
Table 96. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 97. Bayer (Campho Phenique) Recent Development
Table 98. Blistex Company Details
Table 99. Blistex Business Overview
Table 100. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
Table 101. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 102. Blistex Recent Development
Table 103. Kelun Company Details
Table 104. Kelun Business Overview
Table 105. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
Table 106. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 107. Kelun Recent Development
Table 108. Hikma Company Details
Table 109. Hikma Business Overview
Table 110. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
Table 111. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 112. Hikma Recent Development
Table 113. Haiwang Company Details
Table 114. Haiwang Business Overview
Table 115. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
Table 116. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 117. Haiwang Recent Development
Table 118. Carmex Company Details
Table 119. Carmex Business Overview
Table 120. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
Table 121. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 122. Carmex Recent Development
Table 123. Cipher Company Details
Table 124. Cipher Business Overview
Table 125. Cipher Drugs for Herpes Labialis (Oral Herpes) Product
Table 126. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 127. Cipher Recent Development
Table 128. Drugs for Herpes Labialis (Oral Herpes) Market Trends
Table 129. Drugs for Herpes Labialis (Oral Herpes) Market Drivers
Table 130. Drugs for Herpes Labialis (Oral Herpes) Market Challenges
Table 131. Drugs for Herpes Labialis (Oral Herpes) Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2024 VS 2031
Figure 3. Aciclovir Features
Figure 4. Valacyclovir Features
Figure 5. Famciclovir Features
Figure 6. Docosanol Features
Figure 7. Other Features
Figure 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2024 VS 2031
Figure 9. External Use
Figure 10. Oral
Figure 11. Injection
Figure 12. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered
Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2024
Figure 21. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2024
Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 24. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 25. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 26. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 27. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 28. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 29. Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 30. Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 31. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 32. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 33. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 34. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 35. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 36. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 37. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 38. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 39. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 40. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 41. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 42. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 43. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 44. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 45. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 46. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 47. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Region (2020-2025)
Table 6. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2020-2025)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2020-2025)
Table 15. Global Drugs for Herpes Labialis (Oral Herpes) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Drugs for Herpes Labialis (Oral Herpes) Application
Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players (2020-2025)
Table 20. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2024)
Table 21. Ranking of Global Top Drugs for Herpes Labialis (Oral Herpes) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Headquarters and Area Served
Table 24. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Product and Application
Table 25. Global Key Players of Drugs for Herpes Labialis (Oral Herpes), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 29. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 33. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 37. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Company (2020-2025)
Table 41. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Drugs for Herpes Labialis (Oral Herpes) Market Size by Application (2020-2025) & (US$ Million)
Table 43. GSK Company Details
Table 44. GSK Business Overview
Table 45. GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table 46. GSK Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 47. GSK Recent Development
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table 51. Novartis Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Teva Company Details
Table 54. Teva Business Overview
Table 55. Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table 56. Teva Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 57. Teva Recent Development
Table 58. Mylan Company Details
Table 59. Mylan Business Overview
Table 60. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table 61. Mylan Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 62. Mylan Recent Development
Table 63. Cadila Company Details
Table 64. Cadila Business Overview
Table 65. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table 66. Cadila Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 67. Cadila Recent Development
Table 68. Apotex Company Details
Table 69. Apotex Business Overview
Table 70. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table 71. Apotex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 72. Apotex Recent Development
Table 73. Daewoong Pharmaceutical Company Details
Table 74. Daewoong Pharmaceutical Business Overview
Table 75. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table 76. Daewoong Pharmaceutical Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 77. Daewoong Pharmaceutical Recent Development
Table 78. Livzon Company Details
Table 79. Livzon Business Overview
Table 80. Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table 81. Livzon Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 82. Livzon Recent Development
Table 83. Luoxin Company Details
Table 84. Luoxin Business Overview
Table 85. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table 86. Luoxin Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 87. Luoxin Recent Development
Table 88. Med shine Company Details
Table 89. Med shine Business Overview
Table 90. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table 91. Med shine Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 92. Med shine Recent Development
Table 93. Bayer (Campho Phenique) Company Details
Table 94. Bayer (Campho Phenique) Business Overview
Table 95. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
Table 96. Bayer (Campho Phenique) Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 97. Bayer (Campho Phenique) Recent Development
Table 98. Blistex Company Details
Table 99. Blistex Business Overview
Table 100. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
Table 101. Blistex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 102. Blistex Recent Development
Table 103. Kelun Company Details
Table 104. Kelun Business Overview
Table 105. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
Table 106. Kelun Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 107. Kelun Recent Development
Table 108. Hikma Company Details
Table 109. Hikma Business Overview
Table 110. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
Table 111. Hikma Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 112. Hikma Recent Development
Table 113. Haiwang Company Details
Table 114. Haiwang Business Overview
Table 115. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
Table 116. Haiwang Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 117. Haiwang Recent Development
Table 118. Carmex Company Details
Table 119. Carmex Business Overview
Table 120. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
Table 121. Carmex Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 122. Carmex Recent Development
Table 123. Cipher Company Details
Table 124. Cipher Business Overview
Table 125. Cipher Drugs for Herpes Labialis (Oral Herpes) Product
Table 126. Cipher Revenue in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025) & (US$ Million)
Table 127. Cipher Recent Development
Table 128. Drugs for Herpes Labialis (Oral Herpes) Market Trends
Table 129. Drugs for Herpes Labialis (Oral Herpes) Market Drivers
Table 130. Drugs for Herpes Labialis (Oral Herpes) Market Challenges
Table 131. Drugs for Herpes Labialis (Oral Herpes) Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Type: 2024 VS 2031
Figure 3. Aciclovir Features
Figure 4. Valacyclovir Features
Figure 5. Famciclovir Features
Figure 6. Docosanol Features
Figure 7. Other Features
Figure 8. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application: 2024 VS 2031
Figure 9. External Use
Figure 10. Oral
Figure 11. Injection
Figure 12. Drugs for Herpes Labialis (Oral Herpes) Report Years Considered
Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Drugs for Herpes Labialis (Oral Herpes) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. China Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Players in 2024
Figure 21. Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Drugs for Herpes Labialis (Oral Herpes) Revenue in 2024
Figure 23. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 24. North America Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 25. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 26. Europe Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 27. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 28. China Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 29. Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Type (2020-2025)
Figure 30. Japan Drugs for Herpes Labialis (Oral Herpes) Market Share by Application (2020-2025)
Figure 31. GSK Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 32. Novartis Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 33. Teva Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 34. Mylan Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 35. Cadila Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 36. Apotex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 37. Daewoong Pharmaceutical Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 38. Livzon Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 39. Luoxin Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 40. Med shine Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 41. Bayer (Campho Phenique) Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 42. Blistex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 43. Kelun Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 44. Hikma Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 45. Haiwang Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 46. Carmex Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 47. Cipher Revenue Growth Rate in Drugs for Herpes Labialis (Oral Herpes) Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232